Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Daiichi Sankyo Europe Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 26, 2020
Approval ID: 9f8f1df6cfdd0a64
Company: Daiichi Sankyo Europe Gmbh
Type: Standard

Approval Details

Approval Id: 9f8f1df6cfdd0a64
Drug Cima Aemps Name: NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1201425002
Holder Company Name: Daiichi Sankyo Europe Gmbh
Marketing Company Name: Daiichi Sankyo Espana S.A.
Holder Company Detail Path: /organization/daiichi-sankyo-europe-gmbh
Authorization Date: 2020-12-26
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 180 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Daiichi Sankyo Europe Gmbh
Company Detail Path: /organization/daiichi-sankyo-europe-gmbh

Company Information

Pharmaceutical Company Name: Daiichi Sankyo Europe GmbH
Country Name: Germany
City Name: münchen,bayern,country_de
Address: Zielstattstr. 48
Website: http://www.daiichi-sankyo.eu

Active Ingredients

BEMPEDOICO ACIDO

180 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 26, 2020

Approval ID

9f8f1df6cfdd0a64

Type

Standard

Back to CIMA-AEMPS Approvals